Discover Ono Pharmaceutical's groundbreaking patent for autophagy-inhibiting compounds, targeting various cancers with innovative MEK inhibitors like selumetinib.

Geoffrey D. Young, MD, PhD, FACS, discussed the many advances in thyroid cancer management and treatment, highlighting what a ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

After hours: September 23 at 4:01 PM EDT ...

近年来随着治疗靶点的发现和新型靶向药物的不断研发，肿瘤治疗已步入精准治疗新时代。近日，2024 年世界肺癌大会（WCLC）和欧洲肿瘤内科学会（ESMO）年会陆续召开，带来肿瘤领域最新前沿进展。会议中，针对 BRAF、MET 14 ...

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University, in collaboration with the ...

After hours: September 20 at 6:10 PM EDT Loading Chart for VSTM ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...